ConductScience.org, home

Paper6756459

The clinical value of immunohistochemically demonstrable CEA in breast cancer: a possible method of selecting patients for adjuvant chemotherapy.

Smith SR and 3 others. Br J Cancer, 1982. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. The clinical value of immunohistochemically demonstrable CEA in breast cancer: a possible method of selecting patients for adjuvant chemotherapy. Papers, record 6756459. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6756459

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The clinical value of immunohistochemically demonstrable CEA in breast cancer: a possible method of selecting patients for adjuvant chemotherapy.
PubMed
Journal
Br J Cancer
PubMed
Year
1982
PubMed
Publication types
Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
1.15
iCite
Revised in PubMed
2019-05-15
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Smith SRS R
2Howell AA
3Minawa AA
4Morrison JMJ M

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Carcinoembryonic AntigenMajor topic
Clinical Trials as Topic
Female
Humans
Immunoenzyme Techniques
Lymphatic Metastasis
Prognosis

Source PubMed

Download CSV of topics

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16059522Sensitivity of L cells in exponential and stationary phase to 5-fluorouracil.Nature1967https://conductscience.org/library/papers/6059522PubMed
25121665Sensitivity to nitrogen mustard as a function of transport activity and proliferative rate in L5178Y lymphoblasts.Cancer Res1971https://conductscience.org/library/papers/5121665PubMed
34823478Carcinoembryonic antigen in breast cancer patients: serum levels and disease progress.Cancer1974https://conductscience.org/library/papers/4823478PubMed
44858112Survival responses of dividing and nondividing mammalian cells after treatment with hydroxyurea, arabinosylcytosine, or adriamycin.Cancer Res1974https://conductscience.org/library/papers/4858112PubMed
51110084Prognostic factors in colon carcinoma: correlation of serum carcinoembryonic antigen level and tumor histopathology.Hum Pathol1975https://conductscience.org/library/papers/1110084PubMed
61094196Carcinoembryonic antigen (CEA) levels and tumor histology in colon cancer.J Surg Res1975https://conductscience.org/library/papers/1094196PubMed
71156523Changes in sensitivity to cytotoxic agents occurring during the life history of monolayer cultures of a mouse tumour cell line.Br J Cancer1975https://conductscience.org/library/papers/1156523PubMed
8964319Restriction of CEA synthesis to the stationary phase of growth of cultured human colon carcinoma cells.Exp Cell Res1976https://conductscience.org/library/papers/964319PubMed
9872038Biological markers in breast carcinoma. III. Clinical correlations with carcinoembryonic antigen.Cancer1977https://conductscience.org/library/papers/872038PubMed
10872092Antibody-dependent cell-mediated cytolysis of human colon carcinoma cells induced by specific antisera against carcinoembryonic antigen.Cancer Res1977https://conductscience.org/library/papers/872092PubMed
11873641K cell mediated lysis of cultured colon carcinoma and urinary bladder carcinoma cells induced by monospecific antisera against carcinoembryonic antigen (CEA) and two CEA-related normal glycoproteins.Int J Cancer1977https://conductscience.org/library/papers/873641PubMed
12406560Acute leukemia after alkylating-agent therapy of ovarian cancer.N Engl J Med1977https://conductscience.org/library/papers/406560PubMed
13278642Acute myelogenous leukemia in patients receiving chlorambucil as long-term adjuvant chemotherapy for stage II breast cancer.Cancer Treat Rep1978https://conductscience.org/library/papers/278642PubMed
14698698Natural history and prognosis of recurrent breast cancer.Br Med J1978https://conductscience.org/library/papers/698698PubMed
15698917Carcinoembryonic antigen in patients with breast cancer: an adjunctive tool to monitor response and therapy.Cancer1978https://conductscience.org/library/papers/698917PubMed
16365699Correlation of carcinoembryonic antigen in tissue sections with spread of mammary carcinoma.Histopathology1978https://conductscience.org/library/papers/365699PubMed
17435793Carcinoembryonic antigen in breast-cancer tissue: a useful prognostic indicator.Br Med J1979https://conductscience.org/library/papers/435793PubMed
18108040Circulating carcinoembryonic antigen immune complexes in sera of patients with carcinomata of the gastrointestinal tract.Clin Exp Immunol1979https://conductscience.org/library/papers/108040PubMed
19476707Role of plasma carcinoembryonic antigen in evaluating patients with breast cancer treated with adjuvant chemotherapy.Cancer Treat Rep1979https://conductscience.org/library/papers/476707PubMed
20480384Human colon adenocarcinoma cells. III. In vitro organoid expression and carcinoembryonic antigen kinetics in hollow fiber culture.J Natl Cancer Inst1979https://conductscience.org/library/papers/480384PubMed

See all 28 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
6511807Metastatic breast cancer with constantly low CEA blood levels. A subgroup with unfavorable prognosis?J Cancer Res Clin Oncol1984https://conductscience.org/library/papers/6511807PubMed
6203639The detection and evaluation of human tumor metastases.Cancer Metastasis Rev1983https://conductscience.org/library/papers/6203639PubMed
3682432Immunohistochemical demonstration of estrogen, progesterone, CEA and ferritin in breast cancer and their clinical value for the prediction of early postoperative recurrence.Jpn J Surg1987https://conductscience.org/library/papers/3682432PubMed
1649933The clinical value of tissue carcinoembryonic antigen in breast cancer.Jpn J Surg1991https://conductscience.org/library/papers/1649933PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CEACAM31084PubTator's text mininghttps://conductscience.org/library/genes/1084

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6756459

GET https://conductscience.org/api/papers/v1/6756459/references?page=2